BioNTech Announces Second Quarter 2023 Financial Results and ...

Seasonal Flu VaccinesPart B payment allowance limits for seasonal influenza (flu) vaccines (that is, the vaccine product) are 95% of the Average Wholesale ...

Moderna: Pioneering mRNA technology

Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates ... Read our 2023 ESG Report. ESG Picture. Investors. Investors overview ...

Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)

As of November 8, 2024, the registrant had 266,121,689 ordinary shares (including shares in form of ADSs), par value $0.000042 per share, ...

Vaccine maker stocks tumble after Trump picks RFK Jr. for health ...

Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F. Kennedy Jr. to be the ...

African Union: Home

Key Resources. Key(active tab) · All Documents · Reports · Second Continental Report on The Implementation of Agenda 2063. February 10, 2022. Agenda 2063 is ...

COVID is surging again. Here's the latest on new variants, updated ...

The latest, highly contagious subvariants are driving infections, but new vaccines expected this fall may help stem the tide of another ...

Pfizer - Wikipedia

The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in 2023 revenues), a ...

BioNTech to Acquire Biotheus to Boost Oncology Strategy

MAINZ, Germany, November 13, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) today announced the ...

Other news to note for Nov. 14, 2024 | BioWorld

The transaction is expected to close in the first quarter of 2025. It follows an initial exclusive global license and collaboration between the ...

BioNTech to Acquire Biotheus to Boost Oncology Strategy

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) today announced the signing of a definitive agreement for the acquisition ...

COVID-19 vaccines - World Health Organization (WHO)

Financial statements · Internal audit and investigations · Programme Budget · Results reports ... The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need ...

RFK Jr. pick tumbles vaccine stocks - CTV News

Shares of prominent vaccine makers plunged Thursday after U.S. president-elect Donald Trump announced his pick of Robert F. Kennedy Jr. to ...

Bavarian Nordic shares sink by 12% after mpox sales slump in Q3

In its Q3 results, Bavarian Nordic stated that “sales are impacted by outbreaks and/or larger orders from time to time, which make quarterly or ...

Covid-19 - Singapore - Ministry of Health

Where can I get vaccinated? Vaccine Injury Financial Assistance Programme (VIFAP) for COVID-19 vaccination. How is COVID-19 ...

BioNTech to Acquire Biotheus to Boost Oncology Strategy

... 2023, granting BioNTech the rights to develop, manufacture ... The forward-looking statements in this press release are based on BioNTech's ...